Addex Therapeutics logo

Addex Therapeutics Share Price Today

(NASDAQ: ADXN)

Addex Therapeutics share price is $7.7 & ₹669.66 as on 6 Mar 2025, 2.30 'hrs' IST

$7.7

0.09

(1.25%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Addex Therapeutics share price in Dollar and Rupees. Guide to invest in Addex Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Addex Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Addex Therapeutics share price movements

  • Today's Low: $7.25
    Today's High: $7.80

    Day's Volatility :7.05%

  • 52 Weeks Low: $6.67
    52 Weeks High: $27.90

    52 Weeks Volatility :76.09%

Addex Therapeutics (ADXN) Returns

PeriodAddex Therapeutics LtdIndex (Russel 2000)
3 Months
2.26%
0.0%
6 Months
-31.92%
0.0%
1 Year
-15.29%
0.0%
3 Years
-91.97%
-11.6%

Addex Therapeutics (ADXN) Key Statistics

in dollars & INR

Previous Close
$7.605
Open
$7.4
Today's High
$7.8
Today's Low
$7.25
Market Capitalization
$8.6M
Today's Volume
$2.6K
52 Week High
$27.9
52 Week Low
$6.67
Revenue TTM
$592.4K
EBITDA
$-10.9M
Earnings Per Share (EPS)
$-19.61
Profit Margin
912.4%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-168.91%

How to invest in Addex Therapeutics Stock (ADXN) from India?

It is very easy for Indian residents to invest directly in Addex Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Addex Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Addex Therapeutics or ADXN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Addex Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Addex Therapeutics shares which would translate to 0.113 fractional shares of Addex Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Addex Therapeutics, in just a few clicks!

Returns in Addex Therapeutics (ADXN) for Indian investors in Rupees

The Addex Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Addex Therapeutics investment value today

Current value as on today

₹89,657

Returns

₹10,343

(-10.34%)

Returns from Addex Therapeutics Stock

₹15,292 (-15.29%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Addex Therapeutics (ADXN)

75%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Addex Therapeutics Stock from India on INDmoney has increased by 75% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Addex Therapeutics

  • Citadel Advisors Llc

    1.13%

  • Morgan Stanley - Brokerage Accounts

    0.18%

  • GAMMA Investing LLC

    0.09%

  • Rhumbline Advisers

    0.01%

Analyst Recommendation on Addex Therapeutics

Sell

    10%Buy

    20%Hold

    70%Sell

Based on 10 Wall street analysts offering stock ratings for Addex Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
2
3
3
Sell
7
7
7

Analyst Forecast on Addex Therapeutics Stock (ADXN)

What analysts predicted

Upside of 289.61%

Target:

$30.00

Current:

$7.70

Insights on Addex Therapeutics Stock (Ticker Symbol: ADXN)

  • Price Movement

    In the last 3 years, ADXN stock has moved down by -92.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 234.91K → 53.83K (in $), with an average decrease of 52.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 12.87M → -1.52M (in $), with an average decrease of 111.9% per quarter
  • ADXN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 81.8%
  • ADXN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 143.6%
  • Price to Sales

    ForADXN every $1 of sales, investors are willing to pay $10.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

ADXN Addex Therapeutics Financials in INR & Dollars

FY18Y/Y Change
Revenue
$6.1M
↑ 1109.03%
Net Income
$-1.7M
↓ 49.86%
Net Profit Margin
-27.21%
↑ 629.01%
FY19Y/Y Change
Revenue
$2.8M
↓ 54.29%
Net Income
$-15.0M
↑ 798.63%
Net Profit Margin
-534.98%
↓ 507.77%
FY20Y/Y Change
Revenue
$4.1M
↑ 30.77%
Net Income
$-14.5M
↓ 13.0%
Net Profit Margin
-355.92%
↑ 179.06%
FY21Y/Y Change
Revenue
$3.2M
↓ 19.28%
Net Income
$-16.7M
↑ 19.39%
Net Profit Margin
-526.42%
↓ 170.5%
FY22Y/Y Change
Revenue
$1.5M
↓ 51.22%
Net Income
$-22.3M
↑ 35.52%
Net Profit Margin
-1.5K%
↓ 936.15%
FY23Y/Y Change
Revenue
$1.9M
↑ 13.39%
Net Income
$-12.2M
↓ 49.26%
Net Profit Margin
-654.47%
↑ 808.1%
Q2 FY23Q/Q Change
Revenue
$363.9K
↓ 48.05%
Net Income
$-2.9M
↓ 2.17%
Net Profit Margin
-798.54%
↓ 374.5%
Q3 FY23Q/Q Change
Revenue
$170.8K
↓ 53.18%
Net Income
$-3.2M
↑ 9.16%
Net Profit Margin
-1.9K%
↓ 1063.19%
Q4 FY23Q/Q Change
Revenue
$177.5K
↑ 0.0%
Net Income
$-3.3M
↑ 0.0%
Net Profit Margin
-1.9K%
↑ 0.0%
Q1 FY24Q/Q Change
Revenue
$264.3K
↑ 53.08%
Net Income
$-3.5M
↑ 8.06%
Net Profit Margin
-1.3K%
↑ 547.55%
Q2 FY24Q/Q Change
Revenue
$129.0K
↓ 50.93%
Net Income
$14.4M
↓ 517.17%
Net Profit Margin
11.2K%
↑ 12486.08%
Q3 FY24Q/Q Change
Revenue
$53.8K
↓ 53.3%
Net Income
$-1.5M
↓ 111.88%
Net Profit Margin
-2.8K%
↓ 14013.76%
FY18Y/Y Change
Profit
$5.9M
↑ 1154.91%
FY19Y/Y Change
Profit
$2.6M
↓ 57.07%
FY20Y/Y Change
Profit
$-7.6M
↓ 366.92%
FY21Y/Y Change
Profit
$-10.8M
↑ 46.47%
FY22Y/Y Change
Profit
$-14.1M
↑ 33.31%
FY23Y/Y Change
Profit
$-6.2M
↓ 59.68%
Q2 FY23Q/Q Change
Profit
$-1.6M
↑ 19.14%
Q3 FY23Q/Q Change
Profit
$-1.6M
↓ 6.03%
Q1 FY24Q/Q Change
Profit
$264.4K
-
Q2 FY24Q/Q Change
Profit
$129.0K
↓ 50.95%
Q3 FY24Q/Q Change
Profit
$53.8K
↓ 53.3%
FY18Y/Y Change
Operating Cash Flow
$1.8M
↓ 182.05%
Investing Cash Flow
$-56.8K
↑ 7987.66%
Financing Cash Flow
$37.7M
↑ 1014.47%
FY19Y/Y Change
Operating Cash Flow
$-9.6M
↓ 641.3%
Investing Cash Flow
$-44.0K
↓ 23.27%
Financing Cash Flow
$-471.7K
↓ 101.24%
FY20Y/Y Change
Operating Cash Flow
$-13.7M
↑ 28.45%
Investing Cash Flow
$-66.8K
↑ 37.36%
Financing Cash Flow
$52.2K
↓ 110.01%
FY21Y/Y Change
Operating Cash Flow
$-16.0M
↑ 20.73%
Investing Cash Flow
$-32.9K
↓ 48.98%
Financing Cash Flow
$17.8M
↑ 35251.67%
FY22Y/Y Change
Operating Cash Flow
$-17.6M
↑ 11.78%
Investing Cash Flow
$3.2K
↓ 109.8%
Financing Cash Flow
$3.3M
↓ 81.08%
Q2 FY23Q/Q Change
Operating Cash Flow
$-2.5M
↓ 18.34%
Investing Cash Flow
$-2.8K
↑ 0.0%
Financing Cash Flow
$-209.8K
↓ 104.21%

Addex Therapeutics Technicals Summary

Sell

Neutral

Buy

Addex Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Addex Therapeutics (ADXN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Addex Therapeutics Ltd logo
-4.23%
-31.92%
-15.29%
-91.97%
-95.65%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Addex Therapeutics Ltd logo
NA
NA
NA
0.0
-1.69
-0.76
NA
0.11
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Addex Therapeutics Ltd logo
Sell
$8.6M
-95.65%
NA
912.4%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Addex Therapeutics

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia and dystonia, and post-stroke/TBI recovery; ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM) for the treatment of epilepsy; and GABAB PAM for the treatment of pain, anxiety, overactive bladder, and addiction, as well as substance use disorder. Addex Therapeutics Ltd has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the discovery, development, and commercialization of novel mGlu2 PAM compounds for the treatment of CNS and related diseases; license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases; and The Charcot"Marie"Tooth Association to evaluate the role of GABAB PAM compounds in preclinical models of CMT1A. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
Organization
Addex Therapeutics
Employees
23
CEO
Mr. Timothy Mark Dyer
Industry
Health Technology

Management People of Addex Therapeutics

NameTitle
Mr. Timothy Mark Dyer
Co-Founder, CEO & Director
Dr. Roger G. Mills M.D.
Chief Medical Officer & Director
Mr. Lénaic Teyssédou
Head of Finance
Dr. Mikhail Kalinichev Ph.D.
Head of Translational Science

Important FAQs about investing in ADXN Stock from India :

What is Addex Therapeutics share price today?

Addex Therapeutics share price today stands at $7.70, Open: $7.40 ; Previous Close: $7.61 ; High: $7.80 ; Low: $7.25 ; 52 Week High: $27.90 ; 52 Week Low: $6.67.

The stock opens at $7.40, after a previous close of $7.61. The stock reached a daily high of $7.80 and a low of $7.25, with a 52-week high of $27.90 and a 52-week low of $6.67.

Can Indians buy Addex Therapeutics shares?

Yes, Indians can invest in the Addex Therapeutics (ADXN) from India.

With INDmoney, you can buy Addex Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Addex Therapeutics at zero transaction cost.

How can I buy Addex Therapeutics shares from India?

It is very easy to buy Addex Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Addex Therapeutics (ADXN) be purchased?

Yes, you can buy fractional shares of Addex Therapeutics with INDmoney app.

What are the documents required to start investing in Addex Therapeutics stocks?

To start investing in Addex Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Addex Therapeutics Stock (ADXN)?

Today’s highest price of Addex Therapeutics (ADXN) is $7.80.

Today’s lowest price of Addex Therapeutics (ADXN) is $7.25.

What is today's market capitalisation of Addex Therapeutics?

Today's market capitalisation of Addex Therapeutics ADXN is 8.6M

What is the 52 Week High and Low Range of Addex Therapeutics Stock (ADXN)?

  • 52 Week High

    $27.90

  • 52 Week Low

    $6.67

What are the historical returns of Addex Therapeutics (ADXN)?

  • 1 Month Returns

    -4.23%

  • 3 Months Returns

    -31.92%

  • 1 Year Returns

    -15.29%

  • 5 Years Returns

    -95.65%

Who is the Chief Executive Officer (CEO) of Addex Therapeutics ?

Mr. Timothy Mark Dyer is the current Chief Executive Officer (CEO) of Addex Therapeutics.